Horea Rus

University of Maryland, Baltimore — United States

Immunology and Microbiology · Life Sciences

47h-index6.4kcitations203works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Complement system in diseases(59), Multiple Sclerosis Research Studies(26), Neuroinflammation and Neurodegeneration Mechanisms(21), Atherosclerosis and Cardiovascular Diseases(21), Systemic Lupus Erythematosus Research(19)

Publications201 total

RGC-32 regulates nuclear factor I-A and reactive astrocytes during experimental autoimmune encephalomyelitis 2267
The Journal of Immunology·2025Open Access
Levels of C5B-9, RGC-32 and SIRT1 in chronic and acute ischemic coronary artery disease
Atherosclerosis·2025Open Access
Behavior of Complement System Effectors in Chronic and Acute Coronary Artery Disease
Journal of Clinical Medicine·2025Open Access
Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosis
Frontiers in Immunology·2024Open Access
RGC-32 mediates proinflammatory and profibrotic pathways in immune-mediated kidney disease
Clinical Immunology·2024· 2 cited
1005 Response gene to complement-32 facilitates local recruitment of Th1 and Th17 cells and promotes renal inflammation in immune complex mediated glomerulonephritis
2024Open Access
The liver and muscle secreted HFE2-protein maintains central nervous system blood vessel integrity
Nature Communications·2024· 3 citedOpen Access
COVID, complement, and the brain
Frontiers in Immunology·2023· 15 citedOpen Access
RGC-32 facilitates reactive astrocytosis by modulating the expression of axonal guidance molecules
The Journal of Immunology·2023Open Access
1105 Response Gene to Complement-32 expression is upregulated in the kidney and promotes renal fibrosis in lupus nephritis
Innate Immunity·2022Open Access
The liver and muscle secreted Hfe2-protein maintains blood brain barrier integrity
2022Open Access
Role of RGC-32 in multiple sclerosis and neuroinflammation – few answers and many questions
Frontiers in Immunology·2022· 4 citedOpen Access
Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study
Multiple Sclerosis Journal·2022· 4 citedOpen Access
Effect of methotrexate on response to Covid-19 mRNA vaccines in patients with Autoimmune Inflammatory Rheumatic Diseases: a longitudinal study
The Journal of Immunology·2022
RGC-32′ dual role in smooth muscle cells and atherogenesis
Clinical Immunology·2022· 8 cited
The liver and muscle secreted Hfe2-protein maintains blood brain barrier integrity
2021Open Access
513 Response gene to complement -32 facilitates local recruitment of IL-17- producing cells in immune complex mediated glomerulonephritis through the CCR6/CCL20 axis
Abstracts·2021Open Access
Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects Against Pulmonary Fibrosis
American Journal of Respiratory Cell and Molecular Biology·2021· 17 citedOpen Access
RGC-32 Acts as a Hub to Regulate the Transcriptomic Changes Associated With Astrocyte Development and Reactive Astrocytosis
Frontiers in Immunology·2021· 2 citedOpen Access
RGC-32 Facilitates Reactive Astrocytosis in Experimental Autoimmune Encephalomyelitis (EAE) by Maintaining a Mature Phenotype
The Journal of Immunology·2021
page 1 of 11Next →

Frequent Co-authors

Florin Niculescu(35), Cornelia Cudrici(15), Violeta Rus(13), Moon L. Shin(11), Matthew Fosbrink(9), R Vlaicu(8), Cosmin Tegla(8), Sonia I. Vlaicu(8), Tudor C. Badea(6), Dallas Boodhoo(5), Petru Adrian Mircea(5), M L Shin(4), Lucian Soane(4), Teodora Niculescu(3), Peter A. Calabresi(3), A Cristea(3), Alexandru Tatomir(3), Adam M. Kruszewski(3), Armugam P. Mekala(3), Philippe Azimzadeh(3)